Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janowsky

Showing results (301-310 of 362) with videos related to

Pageof 37
Sort By:
Journal of Neurochemistry|August 1, 1987
[3H]GBR-12935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkinson's diseaseA Janowsky, F Vocci, P Berger, et al.
European Journal of Pharmacology|August 10, 2014
The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisitedJordy van Enkhuizen, David S Janowsky, Berend Olivier, et al.
Journal of Neurochemistry|November 5, 1997
Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transportersA J Eshleman, E Stewart, A K Evenson, et al.
Psychopharmacology|April 2, 1999
Antidepressant effects of nicotine in an animal model of depressionY Tizabi, D H Overstreet, A H Rezvani, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2016
Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and ReleaseAmy J Eshleman, Katherine M Wolfrum, John F Reed, et al.
Psychiatry Research|February 1, 1981
Physostigmine induction of depressive symptomatology in normal human subjectsS C Risch, R M Cohen, D S Janowsky, et al.
Alcoholism, Clinical and Experimental Research|May 24, 2001
NMDA receptor subunit mRNA and protein expression in ethanol-withdrawal seizure-prone and -resistant miceJ N Mason, A J Eshleman, J K Belknap, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1989
Biological effect of bright lightW F Byerley, S C Risch, J C Gillin, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 13, 2018
Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake InhibitorMichelle G Baladi, Michael J Forster, Michael B Gatch, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligandK A Neve, R A Henningsen, J M Kinzie, et al.
Pageof 37

Showing results (301-310 of 362) with videos related to

Sort By:
Pageof 37
Journal of Neurochemistry|August 1, 1987
[3H]GBR-12935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkinson's diseaseA Janowsky, F Vocci, P Berger, et al.
European Journal of Pharmacology|August 10, 2014
The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisitedJordy van Enkhuizen, David S Janowsky, Berend Olivier, et al.
Journal of Neurochemistry|November 5, 1997
Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transportersA J Eshleman, E Stewart, A K Evenson, et al.
Psychopharmacology|April 2, 1999
Antidepressant effects of nicotine in an animal model of depressionY Tizabi, D H Overstreet, A H Rezvani, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2016
Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and ReleaseAmy J Eshleman, Katherine M Wolfrum, John F Reed, et al.
Psychiatry Research|February 1, 1981
Physostigmine induction of depressive symptomatology in normal human subjectsS C Risch, R M Cohen, D S Janowsky, et al.
Alcoholism, Clinical and Experimental Research|May 24, 2001
NMDA receptor subunit mRNA and protein expression in ethanol-withdrawal seizure-prone and -resistant miceJ N Mason, A J Eshleman, J K Belknap, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1989
Biological effect of bright lightW F Byerley, S C Risch, J C Gillin, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 13, 2018
Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake InhibitorMichelle G Baladi, Michael J Forster, Michael B Gatch, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligandK A Neve, R A Henningsen, J M Kinzie, et al.
Pageof 37